These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 28683987)
1. Node-Negative Esophageal Cancer With Short-Interval Isolated Metastasis to the Gallbladder: A Case Report. Hart CM; Haisley KR; Lanciault C; Dolan JP Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):115-117. PubMed ID: 28683987 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients. Hulshoff JB; Smit JK; van der Jagt EJ; Plukker JT Am J Surg; 2014 Jul; 208(1):73-9. PubMed ID: 24476969 [TBL] [Abstract][Full Text] [Related]
3. Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma. Goense L; van Rossum PSN; Xi M; Maru DM; Carter BW; Meijer GJ; Ho L; van Hillegersberg R; Hofstetter WL; Lin SH Ann Surg Oncol; 2018 Jun; 25(6):1598-1607. PubMed ID: 29569125 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction. Anderegg MC; Lagarde SM; Jagadesham VP; Gisbertz SS; Immanuel A; Meijer SL; Hulshof MC; Bergman JJ; van Laarhoven HW; Griffin SM; van Berge Henegouwen MI Ann Surg; 2016 Nov; 264(5):847-853. PubMed ID: 27429034 [TBL] [Abstract][Full Text] [Related]
5. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952 [TBL] [Abstract][Full Text] [Related]
6. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. Corsini EM; Foo WC; Mitchell KG; Zhou N; Maru DM; Ajani JA; Hofstetter WL; ; Correa AM; Antonoff MB; Lin SH; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1404-1412.e2. PubMed ID: 33010880 [TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. van Heijl M; Omloo JM; van Berge Henegouwen MI; Hoekstra OS; Boellaard R; Bossuyt PM; Busch OR; Tilanus HW; Hulshof MC; van der Gaast A; Nieuwenhuijzen GA; Bonenkamp HJ; Plukker JT; Cuesta MA; Ten Kate FJ; Pruim J; van Dekken H; Bergman JJ; Sloof GW; van Lanschot JJ Ann Surg; 2011 Jan; 253(1):56-63. PubMed ID: 21233607 [TBL] [Abstract][Full Text] [Related]
8. Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy. Nabavizadeh N; Shukla R; Elliott DA; Mitin T; Vaccaro GM; Dolan JP; Maggiore RJ; Schipper PH; Hunter JG; Thomas CR; Holland JM Dis Esophagus; 2016 Aug; 29(6):614-20. PubMed ID: 26043837 [TBL] [Abstract][Full Text] [Related]
9. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma. Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198 [TBL] [Abstract][Full Text] [Related]
12. Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa. Shapiro J; ten Kate FJ; van Hagen P; Biermann K; Wijnhoven BP; van Lanschot JJ Ann Surg; 2013 Nov; 258(5):678-88; discussion 688-9. PubMed ID: 24096766 [TBL] [Abstract][Full Text] [Related]
13. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma. Franko J; Voynov G; Goldman CD Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139 [TBL] [Abstract][Full Text] [Related]
14. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671 [TBL] [Abstract][Full Text] [Related]